Rep. Aaron Bean

Maddy summaryThe Claiming Age Clarity Act (HR 5284) requires the Social Security Administration to update its official terminology by January 1, 2027. It directs the replacement of specific terms: "early eligibility age" becomes "minimum monthly benefit age," "full retirement age" and "normal retirement age" become "standard monthly benefit age," and "delayed retirement credit" is eliminated, with "maximum monthly benefit age" used instead of age 70 references. This change applies to all Social Security Administration rules, regulations, guidance, and materials, both online and in print, affecting how the agency communicates retirement benefit rules to the public.

Give Kids a Chance Act of 2025 This bill expands the Food and Drug Administration’s (FDA’s) authority with respect to research on rare pediatric diseases, including by permitting the FDA to take enforcement action against drug sponsors that fail to satisfy pediatric study requirements and by reauthorizing programs that support pediatric research.  Specifically, the bill modifies requirements relating to molecularly targeted pediatric cancer investigations to permit research on new drugs in combination with active ingredients that have already been approved, provided certain conditions are met; permits the FDA to take enforcement action against drug sponsors that fail to comply with pediatric study requirements, if such sponsors demonstrated a lack of due diligence in satisfying the requirement; renews the FDA’s authority to award priority review vouchers to sponsors of new products intended to treat rare pediatric diseases through September 30, 2029; and reauthorizes through FY2027 certain funding for the National Institutes of Health to support priority pediatric research.  The bill also provides statutory authority for the FDA’s interpretation of the orphan drug exclusivity period. The bill specifies, consistent with FDA regulations, that the seven-year market exclusivity period for drugs for rare diseases or conditions (i.e., orphan drugs) prohibits the approval of the same drug for the same approved use or indication with respect to the disease or condition. (In Catalyst Pharmaceuticals, Inc. v. Becerra , a court rejected the FDA’s interpretation and held that orphan drug exclusivity extends to all uses or indications for the disease or condition.)

Maddy summaryHR 5107, the Common-Sense Law Enforcement and Accountability Now in DC Act (CLEAN DC Act), repeals D.C. Law 24-345 (the 2022 Comprehensive Policing and Justice Reform Amendment Act). This bill directly affects Washington, D.C.'s policing and justice systems by reversing all changes made under that 2022 law. The key mechanism is a straightforward repeal, restoring all prior District laws as if the 2022 reform had never been enacted. The bill does not introduce new provisions but undoes existing reforms to the District’s law enforcement framework.

Maddy summaryHRES 872 is a symbolic resolution supporting Creutzfeldt-Jakob Disease (CJD) Awareness Day, recognizing CJD as a rare, fatal brain disorder affecting approximately 1-2 people per million annually in the U.S. The resolution does not create new programs or policies but formally acknowledges the disease's impact and the importance of raising public awareness about CJD's rapid progression and challenges for patients and families. It specifically encourages recognition of CJD Awareness Day on November 12, 2025, as a way to highlight this condition. The resolution is non-binding and focuses solely on awareness, not medical research or funding.

Maddy summaryHRES 864 is a ceremonial resolution honoring U.S. veterans on Veterans Day 2025. It does not create new laws or policies but formally recognizes veterans' service and sacrifice, calling on all Americans to observe Veterans Day. The resolution references historical context about Veterans Day's origins (from Armistice Day to honoring all veterans) but contains no concrete policy changes. It directly addresses the general public, urging them to participate in the observance. As a non-binding resolution, it affects no specific individuals or groups through legislative action.

Maddy summaryHR 5926, the Mexican Energy Trade Enforcement Act, requires the U.S. Trade Representative to take specific actions to enforce Mexico's obligations under the USMCA regarding energy trade. It mandates either requesting a dispute resolution panel with Mexico under USMCA rules or demanding Mexico provide non-discriminatory market access for U.S. energy companies during the first USMCA review. The bill directly affects U.S. energy companies operating in Mexico and exporting energy to Mexico, which faced alleged preferential treatment of Mexico's state-owned energy firms (CFE and Pemex). The USTR must report to Congress within 90 days on actions taken under the law.

Maddy summaryThis bill requires Medicare to provide beneficiaries with a clear explanation of benefits within 30 days after receiving care or a service. It amends Medicare rules to mandate that the Health and Human Services Secretary send this summary not later than 30 days following payment (or expected payment) for covered items. The law directly affects Medicare beneficiaries, who will receive timely, transparent information about their coverage and costs. This change aims to simplify understanding of Medicare billing without altering benefit eligibility or coverage rules.

Maddy summaryThis bill ensures that critical firearm-related government operations continue during federal shutdowns. It designates background checks (via the FBI's National Instant Criminal Background Check System), Bureau of Alcohol, Tobacco, Firearms and Explosives enforcement, and firearm export licensing (handled by Commerce and State Departments) as essential services that must remain operational. These functions would be treated as "excepted" under federal law, meaning their employees would continue working even if other government services halt. The bill affects how background checks and firearm export licenses are processed during shutdowns but does not change gun ownership laws or eligibility.

Maddy summaryThis bill requires the federal government to create an automated system that verifies whether healthcare providers applying for a unique health identifier are licensed in good standing by their state. It directly affects healthcare providers who apply for these identifiers, ensuring their state licenses are valid before the identifier is issued. The system must be operational within 30 days of the bill's enactment, checking state licensure status automatically. This change modifies the Social Security Act to add this verification step before issuing identifiers to providers claiming state licensure.

Maddy summaryThis bill requires the Inspector General of the Department of Health and Human Services to submit quarterly reports to specific congressional committees on Medicare and Medicaid fraud. The reports must detail the number of fraud investigations, prosecutions, civil actions, alleged fraud amounts, charges, and exclusions from federal health programs. It mandates these reports for two years after enactment using existing agency funding, with no new money authorized. The bill does not change fraud penalties or refund money to citizens - it is solely a reporting requirement for oversight.